The clinical evidence base for this mechanism is robust: a peer-reviewed study in PLOS ONE confirming significant reductions in visceral adipose tissue with tesamorelin treatment compared to placebo across multiple patient populations supports the clinical rationale for using this peptide specifically for abdominal fat reduction
(The placenta is impermeable to insulin, so maternal insulin does not get there)
doi: 10.3945/ajcn.114.086918 Summary Keywords nutritional interventions, osteoarthritis, metabolism, inflammation, oxidative stress, gut-joint axis Citation Wang Y, Cao Z, Gao Y, Shao P, Gao S, Dong M, Tian Z, Feng Y, Xu J and Xiang C (2025) Nutritional interventions for osteoarthritis: targeting the metabolism-inflammation-oxidative stress axisclinical evidence and translational practice
Please note that Lys105 and homologous residues adopt quite similar positions in the structures of active and inactive glutaredoxins 3